https://www.avient.com/sites/default/files/resources/POL%2520BofA%2520Basic%2520Materials%2520IR%2520Presentation%2520w%2520non-GAAP%252012%252011%25202013.pdf
Platform operating income mix percentage 2005Y* 2008Y* 2010Y* YTD 2013 Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 49.7 $ 48.2 Global Color, Additives and Inks 4.3 28.1 37.7 83.4 Designed Structures and Solutions - - - 21.4 Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 153.0 Performance Products and Solutions 75.7 31.3 54.0 41.8 Distribution 19.5 28.1 42.0 49.7 SunBelt Joint venture 91.9 28.6 18.9 - Corporate (51.5) (425.1) (27.7) (61.7) Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 182.8 Less: Corporate operating expense 51.5 425.1 27.7 61.7 Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 244.5 Specialty platform operating mix percentage 2% 34% 43% 63% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
Platform sales and operating income (OI) 2006Y* YTD 2013 Organic’ Acquisitions** YTD 2013’ Consolidated Global Specialty Engineered Materials Sales $ 345.3 $ 427.2 $ 113.6 $ 540.8 Global Color, Additives and Inks Sales 531.8 608.0 45.7 653.7 Designed Structures and Solutions Sales - - 428.2 428.2 Specialty Platform Sales $ 877.1 $ 1,035.2 $ 587.5 1,622.7 Performance Products and Solutions Sales 1,166.2 473.6 39.2 512.8 PolyOne Distribution Sales 732.8 818.1 - 818.1 Corporate and eliminations (153.7) (106.0) - (106.0) Total Sales $ 2,622.4 $ 2,220.9 $ 626.7 $ 2,847.6 Global Specialty Engineered Materials OI $ 3.9 $ 46.1 $ 2.1 $ 48.2 Global Color, Additives and Inks OI 8.9 78.0 5.4 83.4 Designed Structures & Solutions OI - - 21.4 21.4 Specialty Platform OI $ 12.8 $ 124.1 $ 28.9 $ 153.0 Performance Products and Solutions OI 64.2 38.1 3.7 41.8 PolyOne Distribution OI 19.2 49.7 - 49.7 Sunbelt Joint Venture OI 102.9 - - - Corporate and eliminations (4.6) (39.5) - (39.5) Special items in OI 39.1 (22.2) - (22.2) Operating income GAAP $ 233.6 $ 150.2 $ 32.6 $ 182.8 Sunbelt equity income (107.0) - - - Special items in OI (39.1) 22.2 - 22.2 Operating income adjusted $ 87.5 $ 172.4 $ 32.6 $ 205.0 Global Specialty Engineered Materials - OI % of sales 1.1% 10.8% 1.8% 8.9% Global Color, Additives and Inks - OI % of sales 1.7% 12.8% 11.8% 12.8% Designed Structures & Solutions - OI % of sales - - 5.0% 5.0% Specialty platform OI - % of sales 1.5% 12.0% 5.0% 9.4% PP&S operating OI - % of sales 5.5% 8.0% 9.4% 8.2% Distribution OI - % of sales 2.6% 6.1% - 6.1% PolyOne OI adjusted - % of sales 3.3% 7.8% 5.2% 7.2% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment. ** Spartech and Glasforms results for the nine months ended September 30, 2013.
Spartech results reflect results since the date of acquisition. “””Three Months Ended ‘’’’’September 30, Platform operating income “””””””2013 2012 (a) Global Specialty Engineered Materials $ 15.7 $ 13.1 Global Color, Additives and Inks 28.7 18.6 Designed Structures and Solutions 10.9 – Specialty Platform 55.3 31.7 Performance Products and Solutions 14.3 12.3 PolyOne Distribution 16.6 16.4 Corporate and eliminations (24.6) (16.9) Operating income $ 61.6 $ 43.5 (a) Adjusted to reflect the resins business as a discontinued operation.
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
Design times can be less than three days for colorants.
There are significant revenue opportunities generated from the combined color and additive technology strengths of the two legacy companies.
APPENDIX Performance Additives 15% Pigments 15% TiO2 12% Dyestuffs 4%Polyethylene 10% Nylon 5% Polypropylene 4% Other Raw Materials 29% Styrenic Block Copolymer 6% ~1/3 hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 34 • In Q2 2021, several raw material markets experienced significant price inflation and tight inventory o Average cost of hydrocarbon based materials was up 45% year-over-year and 20% sequentially o Average cost of non-hydrocarbon based materials was up 10% year-over-year and 8% sequentially • Additionally, we experienced other supply chain challenges during Q2 related to raw material spot purchases, freight constraints and productivity loss as a result of these shortages Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2020 pro forma purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% EMEA 26% Asia 16% Latin America 8% 2021 YTD SEGMENT, END MARKET AND GEOGRAPHY 36 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 20% Industrial 16% Building and Construction 9% Telecommunications 4% Energy 2% END MARKET REVENUE (1) Total company sales and EBITDA of $2,398M and $320M, respectively, include intercompany sales eliminations and corporate costs All charts reflect YTD financials through June 30 $1,234M $228M $457M $87M $767M $48M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $320M$2,398M (1) Transportation 12% Healthcare 14% Packaging 34% Consumer 21% Healthcare 7% Industrial 16% Building & Construction 10% Transportation 9% Energy 2% Telecommunications 1% C O L O R , A D D I T I V E S & I N K S 2021 YTD REVENUE | $1 .2 BILL ION US & Canada 31% EMEA 42% Asia 21% Latin America 6% END MARKET REGION 37 All charts reflect 2021 YTD financials through June 30 S P E C I A LT Y E N G I N E E R E D M AT E R I A L S Consumer 28% Healthcare 10% Packaging 6% Telecommunications 16% Industrial 12% Transportation 11% Building & Construction 10% Energy 7% 2021 YTD REVENUE | $457 MILLION END MARKET US & Canada 54% EMEA 26% Asia 20% REGION 38 All charts reflect 2021 YTD financials through June 30 DI S TR IBU T I ON Healthcare 27% Consumer 22% Packaging 5% Industrial 20% Transportation 16% Building and Construction 8% Energy 1% Telecommunications 1% US & Canada 81% Asia 4% Latin America 15% END MARKET REGION K E Y S U P P L I ER S 2021 YTD REVENUE | $767 MILLION 39 All charts reflect 2021 YTD financials through June 30 TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET Packaging 30% Consumer 27%Healthcare 11% Industrial 15% Building & Construction 5% Telecommunications 2% Energy 2% Asia (16% of sales) Transportation 8% Packaging 32% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 11% Telecommunications 5% Energy 4% EMEA (26% of sales) Transportation 12% 40 Consumer 25% Healthcare 19% Packaging 11% Industrial 16% Building & Construction 10% Telecommunications 4% Energy 2% US & Canada (50% of sales) Transportation 13% Packaging 40% Consumer 33% Healthcare 4% Industrial 10% Building & Construction 5% Telecommunications 1% LATAM (8% of sales) Transportation 7% All charts reflect 2021 YTD financials through June 30 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Three Months Ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating income $ 108.1 $ 14.2 $ 122.3 Income from continuing operations before income taxes $ 89.8 $ 14.2 $ 104.0 Income tax expense - GAAP (20.4) — (20.4) Income tax impact of special items — (3.4) (3.4) Tax adjustments — 0.9 0.9 Net income attributable to noncontrolling interests (0.6) — (0.6) Net income from continuing operations attributable to Avient shareholders $ 68.8 $ 11.7 $ 80.5 Net income / EPS $ 0.74 $ 0.13 $ 0.87 Weighted-average diluted shares 92.4 92.4 92.4 Three Months Ended September 30, 2020 Reconciliation to Condensed Consolidated Statements of Income GAAP Results Special Items Adjusted Results Operating income $ 33.5 $ 40.4 $ 73.9 Income from continuing operations before income taxes $ 5.3 $ 50.0 $ 55.3 Income tax expense - GAAP (2.7) — (2.7) Income tax impact of special items — (12.7) (12.7) Tax adjustments — 3.0 3.0 Net income attributable to noncontrolling interests (0.9) — (0.9) Net income from continuing operations attributable to Avient shareholders $ 1.7 $ 40.3 $ 42.0 Net income / EPS $ 0.02 $ 0.44 $ 0.46 Weighted-average diluted shares 91.9 91.9 91.9 Three Months Ended Year Ended December 31, Reconciliation to Pro Forma Adjusted EBITDA June 30, 2021 March 31, 2021 June 30, 2020 2020 2019 Net income from continuing operations – GAAP $ 69.4 $ 79.7 $ 23.4 $ 133.8 $ 75.7 Income tax expense 20.4 22.9 7.9 5.2 33.7 Interest expense 19.5 19.3 16.2 74.6 59.5 Depreciation and amortization from continuing operations 33.8 37.1 20.9 115.0 78.1 EBITDA $ 143.1 $ 159.0 $ 68.4 $ 328.6 $ 247.0 Special items, before tax 14.2 2.4 2.4 66.2 61.7 Interest expense included in special items — — (0.5) (10.1) — Depreciation and amortization included in special items 1.4 (0.5) (1.2) (3.2) — Adjusted EBITDA $ 158.7 $ 160.9 $ 69.1 $ 381.6 $ 308.7 Clariant MB pro forma adjustments(1) — — 37.0 75.1 133.2 Pro forma adjusted EBITDA $ 158.7 $ 160.9 $ 106.1 $ 456.7 $ 441.9 (1) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 1 Reconciliation of EBITDA by Segment Three Months Ended June 30, Six Months Ended June 30, Year Ended December 31, 2021 2020 2021 2020 2019 2018 Sales: Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 483.3 $ 1,502.9 $ 1,003.8 Specialty Engineered Materials 240.6 158.8 457.1 344.1 708.8 745.7 Distribution 404.4 238.8 767.1 528.3 1,110.3 1,192.2 Corporate and eliminations (34.2) (15.3) (60.4) (35.1) (79.9) (79.0) Sales $ 1,235.2 $ 609.1 $ 2,397.5 $ 1,320.6 $ 3,242.1 $ 2,862.7 Operating income: Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 180.8 $ 147.4 $ 158.5 Specialty Engineered Materials 37.3 17.0 71.5 94.4 83.7 72.3 Distribution 23.7 14.6 47.7 69.5 75.4 71.5 Corporate and eliminations (39.2) (25.9) (65.8) (155.4) (149.7) (123.7) Operating income $ 108.1 $ 38.0 $ 228.5 $ 189.3 $ 156.8 $ 178.6 Items below OI in Corporate: Other income, net $ 1.2 $ 9.5 $ 2.7 $ 24.3 $ 12.1 $ (12.9) Depreciation & amortization: Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 75.1 $ 42.7 $ 44.3 Specialty Engineered Materials 8.1 7.6 15.9 30.0 29.5 23.2 Distribution 0.2 0.1 0.4 0.7 0.5 0.7 Corporate and eliminations 0.2 2.6 2.0 9.2 5.4 4.4 Depreciation & Amortization $ 33.8 $ 20.9 $ 70.9 $ 115.0 $ 78.1 $ 72.6 EBITDA: Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 255.9 $ 190.1 $ 202.8 Specialty Engineered Materials 45.4 24.6 87.4 124.4 113.2 95.5 Distribution 23.9 14.7 48.1 70.2 75.9 72.2 Corporate and eliminations (39.0) (23.3) (63.8) (146.2) (144.3) (119.3) EBITDA $ 143.1 $ 68.4 $ 302.1 $ 328.6 $ 247.0 $ 238.3 EBITDA as a % of Sales: Color, Additives and Inks 17.9 % 18.9 % 18.5 % 17.0 % 18.9 % 19.4 % Specialty Engineered Materials 18.9 % 15.5 % 19.1 % 17.6 % 15.2 % 14.8 % Distribution 5.9 % 6.2 % 6.3 % 6.3 % 6.4 % 5.7 % 2 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Three Months Ended June 30, Six Months Ended June 30, Year Ended December 31, 2021 2020 2021 2020 2019 2018 Sales: Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 1,502.9 $ 1,003.8 $ 1,046.5 Clariant MB pro forma adjustments(1) — 261.1 — 540.4 1,118.6 1,209.8 Pro forma sales $ 624.4 $ 487.9 $ 1,233.7 $ 2,043.3 $ 2,122.4 $ 2,256.3 Operating income: Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 180.8 $ 147.4 $ 158.5 Clariant MB pro forma adjustments(1) — 22.0 — 45.0 72.9 80.3 Pro forma operating income $ 86.3 $ 54.3 $ 175.1 $ 225.8 $ 220.3 $ 238.8 Depreciation & amortization: Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 75.1 $ 42.7 $ 44.3 Clariant MB pro forma adjustments(1) — 15.0 — 30.1 60.3 61.2 Pro forma depreciation & amortization $ 25.3 $ 25.6 $ 52.6 $ 105.2 $ 103.0 $ 105.5 EBITDA Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 255.9 $ 190.1 $ 202.8 Clariant MB pro forma adjustments(1) — 37.0 — 75.1 133.2 141.5 Pro forma EBITDA $ 111.6 $ 79.9 $ 227.7 $ 331.0 $ 323.3 $ 344.3 Pro forma EBITDA as a % of Sales 17.9 % 16.4 % 18.5 % 16.2 % 15.2 % 15.3 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Three Months Ended June 30, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 609.1 $ — $ 609.1 $ 261.1 $ 870.2 Operating income $ 38.0 $ 9.0 $ 47.0 $ 22.0 $ 69.0 Interest expense, net (16.2) — (16.2) (5.3) (21.5) Other income, net 9.5 (6.6) 2.9 — 2.9 Income taxes (7.9) 0.2 (7.7) (3.8) (11.5) Net income attributable to noncontrolling interests (0.4) — (0.4) — (0.4) Net income from continuing operations attributable to Avient shareholders $ 23.0 $ 2.6 $ 25.6 $ 12.9 $ 38.5 Weighted average diluted shares 91.8 Pro forma adjusted EPS $ 0.42 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 3 Year Ended December 31, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5 Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0 Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6) Other income, net 24.3 (17.6) 6.7 — 6.7 Income taxes (5.2) (41.4) (46.6) (6.2) (52.8) Net income attributable to noncontrolling interests (1.8) — (1.8) — (1.8) Net income from continuing operations attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January 2020 equity offering 1.5 Pro forma weighted average diluted shares 92.1 Pro forma adjusted EPS $ 1.93 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Year Ended December 31, 2019 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3 Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4 Interest expense, net (59.5) — (59.5) (33.4) (92.9) Other income, net 12.1 (10.0) 2.1 — 2.1 Income taxes (33.7) (5.9) (39.6) (9.1) (48.7) Net income attributable to noncontrolling interests (0.2) — (0.2) — (0.2) Net income from continuing operations attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7 Weighted average diluted shares 77.7 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 93.0 Pro forma adjusted EPS $ 1.74 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 4 AVNT Seaport Conference Presentation.pdf AVNT Q2 2021 Earnings Presentation - Website.pdf AVNT Q2 2021 Earnings Presentation - Website.pdf Final - 7.19 1158am Q2 21 IR Deck Version v2
https://www.avient.com/sites/default/files/2020-09/bettcher-case-study-1.pdf
The final solution was pre-colored to match the brand’s existing color palette and eliminate the need for secondary processing steps.
https://www.avient.com/sites/default/files/2021-04/versalloy-medical-tubing-case-study.pdf
The hose manufacturer decided to explore other material options that would meet requirements such as excellent colorability, good surface appearance, high flow for optimal productivity, and of course, compliance with U.S.
In addition to its excellent colorability and high flow, the Versalloy solution possessed a lower specific gravity and resulted in lower scrap rates compared to the competitive TPV, providing the opportunity to reduce system costs.
https://www.avient.com/sites/default/files/2022-12/reSound Ultra Low Carbon Footprint TPE Product Bulletin_0.pdf
These sustainable materials are also customizable, but changes to color or formulation to achieve application-specific needs will require the product carbon footprint to be recalculated.
KEY CHARACTERISTICS • Negative, neutral, or low PCF • Available in 60 and 80 Shore A • Performs like traditional TPEs • Naturally opaque and easy to color • Suitable to injection mold, or overmold onto PP and PE MARKETS & APPLICATIONS The portfolio of reSound ultra-low carbon footprint TPEs is ideal for brand owners and manufacturers who prefer to use a more sustainable material in personal care, household appliance, consumer electronics, and consumer packaging applications.
https://www.avient.com/sites/default/files/2020-08/gravi-tech-closures-case-study.pdf
In addition to cost savings, replacing metal would enable the closure producer to provide its spirits customers with customization in density and color, because Gravi-Tech formulations are colorable, and can be tuned to replicate up to 5 times the density of traditional polymers.
https://www.avient.com/sites/default/files/2022-12/Cesa Fiber Additives Light Stabilizers Product Bulletin.pdf
Cesa™ Fiber Additives Light Stabilizers for Synthetic Fibers and Nonwovens Non UV-stabilized fibers exposed to sunlight can suffer color fading and molecular changes that degrade their chemical and mechanical properties, leading to fraying and breakages.
KEY BENEFITS Avient’s UV stabilizers for fibers provide the following benefits: • High active ingredient loading options available • Little or no effect on processing speeds so plant productivity can be maintained at the highest levels • Resistance to interaction with fertilizers, pesticides and bleaching agents in the manufacturing and end-use environment • Can be combined with colors and with other additives (e.g., flame retardants) into a single combination concentrate for convenience • Product guidance and technical assistance from our experts PRODUCT BULLETIN Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
Avient provides pre-tested color and additive concentrates based on bio-polymers to minimize the risk of non-compliance and support a more sustainable profile for plastic products used in the healthcare industry.
KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-03/ColorMatrix Amosorb rPET Booster Product Bulletin.pdf
Amosorb 4020R improves the aesthetics of recycled packaging in terms of haze and color, and also maintains performance levels irrespective of the level of rPET used, delivering consistent results at all levels of rPET; 25%, 50% and 100%.
KEY BENEFITS • Consistent performance with all levels of rPET; 25%, 50% and 100% • Improved haze and color • Can be used with many different resin/grades • Non-nylon based • Simple to use with existing mono-layer equipment • Suitable for use on multi-layer machines Sustainability Spotlight Recycle Solutions TARGET MARKET & APPLICATIONS PET and rPET rigid packaging for food & beverage REGULATORY ColorMatrix Amosorb 4020R meets direct food contact regulatory requirements in major markets.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
Mevopur™ Healthcare Functional Additives Nucleating Agents Colors are used in the medical industry for brand recognition, the coding of different pharmaceuticals, or visual appeal.
However, pigments used to color plastic parts can cause warping or shrinking, leading to dosing inaccuracy or even malfunctioning healthcare devices.